SVCM
Saturn V Capital Management Portfolio holdings
AUM
$247M
This Quarter Return
+40.7%
1 Year Return
+2.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$261M
AUM Growth
+$261M
(+9.3%)
Cap. Flow
-$28.1M
Cap. Flow
% of AUM
-10.75%
Top 10 Holdings %
Top 10 Hldgs %
74.44%
Holding
26
New
6
Increased
7
Reduced
10
Closed
3
Top Buys
| 1 |
argenx
ARGX
|
$15.6M |
| 2 |
Merus
MRUS
|
$9.6M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$8.56M |
| 4 |
Disc Medicine
IRON
|
$3.74M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
$3.14M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$14.4M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$12.8M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$12.1M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$8.84M |
| 5 |
Biogen
BIIB
|
$8.33M |
Sector Composition
| 1 | Healthcare | 100% |